They would run out of money eventually or end up holding all the stock and should have considered a buy back or take the company private again.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025